Senseonics Q2 revenue jumps, raises 2026 outlook
Senseonics Q2 revenue jumps, raises 2026 outlook
Overview
U.S. glucose monitoring tech firm's Q2 revenue rose 120% yr/yr to $14.5 mln
Gross margin expanded to 59%, up from 47% a year ago
Company raised full-year 2026 revenue and margin guidance
Outlook
Senseonics raises 2026 revenue guidance to $62 mln-$66 mln from $60 mln-$64 mln
Company lifts 2026 gross margin guidance to 58%-61% from 55%-58%
Company expects Europe to contribute about 20% of 2026 revenue as timing normalizes
Result Drivers
IN-HOUSE COMMERCIAL OPERATIONS - Co said bringing U.S. commercial operations in-house drove revenue and margin expansion
U.S. COMMERCIAL MOMENTUM - Co reported record shipment volume and 130% yr/yr increase in active prescribers in U.S.
EON CARE NETWORK - Co scaled Eon Care nurse network to cover 40% of insertion procedures, supporting growth
Company press release: ID:nGNX7SMTqM
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q2 Loss Per Share |
| $0.63 |
|
Q2 Net Loss |
| $36.71 mln |
|
Q2 Gross Profit |
| $8.56 mln |
|
Q2 Operating Income |
| -$35.99 mln |
|
Analyst Coverage
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 4 "strong buy" or "buy", 2 "hold" and 1 "sell" or "strong sell"
The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy."
Wall Street's median 12-month price target for Senseonics Holdings Inc is $14.00, about 170.3% above its August 5 closing price of $5.18
Reuters Recommended Reads
Aug 5 - Insulet cuts sales growth forecast on slower US insulin-pump sales; shares fall
Aug 5 - Nyxoah Q2 revenue surges on U.S. growth, but margins drop
Aug 4 - Revvity raises annual profit, revenue forecasts on strong diagnostics demand
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Recent news on Senseonics Holdings
See all newsDiabetes device firm Beta Bionics jumps after boosted $150 mln equity raise
Diabetes device firm Beta Bionics falls on $150 mln equity raise
Diabetes device firm Beta Bionics slides on $125 mln stock offering plans
Senseonics Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
Senseonics Q2 revenue jumps, raises 2026 outlook